| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3660 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1883 | 2021 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1679 | 2020 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 843 | 2021 |
| Triplex real-time RT-PCR for severe acute respiratory syndrome coronavirus 2 JJ Waggoner, V Stittleburg, R Pond, Y Saklawi, MK Sahoo, A Babiker, ... Emerging infectious diseases 26 (7), 1633, 2020 | 116 | 2020 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 98 | 2022 |
| ACTT-2 Study Group Members AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J …, 2021 | 60 | 2021 |
| Pharmacists’ views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study F El-Jardali, R Fadlallah, RZ Morsi, N Hemadi, M Al-Gibbawi, M Haj, ... Implementation Science 12, 1-13, 2017 | 36 | 2017 |
| Treatable genetic metabolic epilepsies L Assi, Y Saklawi, PE Karam, M Obeid Current Treatment Options in Neurology 19, 1-16, 2017 | 16 | 2017 |
| The role of systems vaccinology in understanding the immune defects to vaccination in solid organ transplant recipients N Scanlon, Y Saklawi, N Rouphael Frontiers in Immunology 11, 582201, 2020 | 11 | 2020 |
| Daily fosfomycin versus levofloxacin for complicated urinary tract infections N Rouphael, P Winokur, MC Keefer, J Traenkner, A Drobeniuc, Y Doi, ... Mbio 14 (5), e01677-23, 2023 | 4 | 2023 |
| Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials II Siempos, AC Kalil, D Belhadi, VC Veiga, AB Cavalcanti, ... EClinicalMedicine 69, 2024 | | 2024 |
Nadine RouphaelProfessor, Emory University在 emory.edu 的电子邮件经过验证
